Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ERN1 | O75460 | 4/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.40 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12961839 | 0.89 | SRC (0.47) | CA1CA2SRCALDH1A1HPGD | |
| SCHEMBL12961813 | 0.89 | CA1 (0.41) | CA1CA2SRCALDH1A1BACE1 | |
| SCHEMBL3214106 | 0.84 | ALDH1A1 (0.47) | CA1CA2SRCALDH1A1BACE1 | |
| SCHEMBL2043979 | 0.84 | PTPN1 (0.53) | CA1CA2SRCALDH1A1BACE1 | |
| SCHEMBL1806253 | 0.83 | CA1 (0.45) | CA1CA2SRCALDH1A1BACE1 | |
| SCHEMBL9454738 | 0.83 | CA1 (0.67) | CA1CA2SRCALDH1A1BACE1 | |
| SCHEMBL29940732 | 0.83 | CA1 (0.45) | CA1CA2SRCALDH1A1BACE1 | |
| SCHEMBL27806563 | 0.83 | CA1 (0.45) | CA1CA2SRCALDH1A1BACE1 | |
| SCHEMBL17531796 | 0.83 | CA1 (0.45) | CA1CA2SRCALDH1A1BACE1 | |
| SCHEMBL28272003 | 0.83 | CA1 (0.45) | CA1CA2SRCALDH1A1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7151070-B2 | Chiral catalyst, process for preparing the same and its use in the oxidate coupling of naphthols | CHENGDU INSTITUTE OF ORGANIC CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) | 2006-12-19 | — | — | US | disclosed |
| US-20050256345-A1 | Chiral catalyst, process for preparing the same and its use in the oxidate coupling of naphthols | CHENGDU INSTITUTE OF ORGANIC CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256345-A1 | Chiral catalyst, process for preparing the same and its use in the oxidate coupling of naphthols | BCAT2, BCAT1, NDUFV2 | CA1 3594/4885CA2 2422/4885SRC 945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.